GlassScriptPhysician profile
Saloni A Patel
NPI 1598713067
$7,450.84
in general payments reported to CMS, 2019-2025
33 companies · $1,554 in 2025
The $1,554 reported for 2025 was more than what 94% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $691 · 2022: $1,541 · 2023: $1,980 · 2024: $1,686 · 2025: $1,554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,790 · Education: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,789.81 |
| Education | $429.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,611.80 | 2021-2025 | |
| Genzyme Corporation | $1,146.87 | 2021-2025 | |
| Incyte Corporation | $733.74 | 2021-2025 | Opzelura, Opzelura |
| Janssen Biotech, INC. | $671.73 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Regeneron Healthcare Solutions, INC. | $536.29 | 2021-2025 | Dupixent, Libtayo |
| Ucb, INC. | $395.10 | 2023-2025 | Bimzelx, Cimzia |
| Arcutis Biotherapeutics, INC. | $255.88 | 2023-2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $240.38 | 2022-2025 | |
| Dermavant Sciences, INC. | $204.22 | 2023-2024 | Vtama |
| Lilly USA, LLC | $170.80 | 2021-2025 | Ebglyss, Taltz, Olumiant |
| Sun Pharmaceutical Industries INC. | $142.98 | 2022-2023 | |
| Pfizer INC. | $134.13 | 2022-2023 | |
| Boston Scientific Corporation | $131.93 | 2024-2025 | General - Dbs |
| Janssen Scientific Affairs, LLC | $124.99 | 2022 | |
| Heron Therapeutics, INC. | $121.91 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $108.13 | 2022-2025 | Sotyktu |
| Sanofi-Aventis U.S. LLC | $99.99 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $92.07 | 2021-2024 | Siliq, Jublia |
| Galderma Laboratories, L.P. | $85.94 | 2021-2025 | Nemluvio, Dysport |
| Biohaven Pharmaceutical Holding Company LTD. | $72.03 | 2022 | |
| Kyowa Kirin, INC. | $55.29 | 2024-2025 | Poteligeo |
| Organon LLC | $46.79 | 2025 | Vtama |
| Allergan, INC. | $46.23 | 2022 | |
| Amgen INC. | $33.39 | 2023 | Otezla |
| Sanofi US Services INC. | $31.98 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.93 | 2023 | Spevigo |
| Botanix Sb INC | $23.99 | 2025 | Sofdra |
| Glaxosmithkline, LLC. | $22.91 | 2023 | Arexvy, Shingrix, Bexsero |
| Biofrontera INC. | $20.85 | 2022 | |
| Bausch Health US, LLC | $20.59 | 2023 | Targretin |
| Almirall LLC | $15.57 | 2024 | Klisyri |
| Epi Health, LLC | $13.34 | 2021 | |
| Micro-Tech Endoscopy USA, INC. | $12.07 | 2024 | Clips |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saloni Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.